David's primary research leverages high-throughput combinatorial screening methods to dissect the functional pleiotropy of receptor-ligand interactions in tissue homeostasis and tumorigenesis, providing new avenues for therapeutic intervention. By integrating these approaches, he is working to understand how inflammation alters the cell fates and functional states of parenchymal and ancillary cell populations in ways that ultimately permit tumorigenesis.